2-(4'-(Diphenylamino)-[1,1'-biphenyl]-4-yl)acetonitrile, 98%, 5g

2-(4-Methoxy-phenoxy)-2-methyl-propionic acid, 95.0%, 1g

(S)-3-Aminomethyl-1-Boc-piperidine, 98.0%, 25g

5-p-Tolyl[1,3,4]thiadiazol-2-ylamine, 95.0%, 1g

1-(4-Aminopiperidin-1-yl)-2,2,2-trifluoroethan-1-one hydrochloride, 97%, 100mg

(S)-1-(4-Bromophenyl)ethanol, 95.0%, 5g

D-Allo-Threonine, 98.0%, 100g

N-(4-nitrobenzyl)-1-adamantanamine hydrobromide, 95.0%, 1g

2-(3-((1,3-Dioxolan-2-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-bromopent-4-enoic acid, 95+%, 100mg

1,3-butanediol, min. 99%, for synthesis, 1 l, plastic packaging.

5-Ethynylpyridin-2-amine, 95.0%, 10g

Fmoc-NH-PEG8-NHS ester, 250mg